Ischemic Mitral Regurgitation Clinical Trial
Official title:
Ranolazine Effects on Ischemic Mitral Regurgitation Severity in Patients With Cardiac Resynchronization Therapy
The purpose of this study is to find out whether mitral regurgitation (or a leaky heart valve) caused by ischemic heart disease (decreased blood flow to heart muscle) will improve after administration of ranolazine.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04396379 -
Epicardial Mitral Touch System for Mitral Insufficiency
|
N/A | |
Not yet recruiting |
NCT04106648 -
Effect of Significant Ischemic Mitral Regurgitation on the Outcome of ST Segment Elevation Myocardial Infarction Patients Treated With Primary Percutaneous Coronary Intervention
|
||
Recruiting |
NCT05469165 -
Serotonin Receptor Blockers in Ischemic Mitral Regurgitation
|
Phase 2 | |
Suspended |
NCT04023058 -
Stress Echo for Ischemic Mitral Valve Surgery
|
N/A |